Related Experiment Video
Updated: Jan 26, 2026

Development of a Larval Zebrafish Infection Model for Clostridioides difficile
Published on: February 14, 2020
Modified Mouse Model of Clostridioides difficile Infection as a Platform for Probiotic Efficacy Studies.
T J De Wolfe1,2, A E Kates2,3, L Barko2
1Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA tjdewolfe@gmail.com.
Probiotics show promise in reducing Clostridioides difficile infections (CDI). This study found that probiotic treatment delayed CDI onset and relapse in a mouse model, suggesting a potential non-antibiotic approach for CDI management.
Area of Science:
- Microbiology
- Gastroenterology
- Immunology
Background:
- Clostridioides difficile infections (CDIs) pose a significant clinical challenge.
- Previous human trials suggest probiotics may reduce CDI duration and alter gut microbiota.
- A need exists for reliable preclinical models to evaluate non-antibiotic CDI interventions.
Purpose of the Study:
- To modify a CDI mouse model to better reflect human clinical outcomes.
- To investigate the efficacy of Lactobacillus and Bifidobacterium probiotics in preventing primary CDI and relapse in this model.
- To identify microbial changes associated with probiotic intervention during CDI.
Main Methods:
- A cefoperazone-induced CDI mouse model was established.
- Mice received either probiotics or placebo during antibiotic treatment and infection challenge.
- Clinical scoring, survival analysis, and 16S rRNA sequencing of stool were performed.
Main Results:
- Probiotic treatment significantly delayed the onset of primary CDI and relapse by 12-24 hours (P < 0.001).
- Mice receiving probiotics showed delayed CDI onset and improved survival.
- Stool microbiome analysis revealed enrichment of Lachnospiraceae in probiotic-treated mice with moderate CDI (P < 0.05).
Conclusions:
- The modified CDI mouse model effectively recapitulates key clinical and microbial features of human CDI.
- Lactobacillus and Bifidobacterium probiotics demonstrate preventative effects against primary CDI and relapse in this model.
- This model provides a valuable platform for further investigation of non-antibiotic strategies for CDI prevention and treatment.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Self-Efficacy
Modified Boxplots
However, the box plot does not tell the reader about outliers - values that lie far from the center of the data. We can modify the standard box and whisker plot to identify the outliers and visualize the actual spread of the data in a sample.
Initially, we calculate the adjusted...
Typical Model Studies
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Dose-Response Relationship: Potency and Efficacy

